Related Content

Alzheimer's Disease

The abnormal protein deposits found in the brains of people with Alzheimer's disease may be involved in the loss of cognitive function that characterizes the disorder.


Vascular Dementia

Vascular dementia is impairment of memory and cognitive functioning that is caused by cerebrovascular disease.

Meningitis

Among the possible sources of meningeal inflammation are viral or bacterial infection and brain injury or surgery.


NACDS Applauds Increased Dispensing Fee in Texas



Dermatologic Signs of Rheumatoid Arthritis

Rheumatoid arthritis, the most common inflammatory arthritis, is a chronic autoimmune disease and an important cause of disability in seniors.

HIV/AIDS

First Nucleic Acid Test for Additional HIV Strains 2/20/2009



Sexual Activity and STDs Among Seniors 8/19/2008

S exually transmitted diseases (STDs) ( TABLE 1 ) can be contracted later in life--a fact too often overlooked by seniors and health care providers alike.

AIDS Virus in U.S. Longer Than Originally Believed 2/20/2008

A study by a University of Arizona evolutionary biologist that was published in the Proceedings of the National Academy of Sciences uncovered that the AIDS virus was causing infections in the U.S. approximately 12 years before scientists officially recognized it as a disease in 1981.

Cancer/AIDS News 9/19/2007

Many Cancers Signal HIV/AIDS More infection-related cancers result from immunodeficiencies than previously thought, according to a meta-analysis reported in Lancet .

Cancer/AIDS News 8/20/2007

Genes May Have Role in Colorectal and Prostate Cancers Several studies suggest there may be a common genetic link to the development of colorectal and prostate cancers.

Cancer/AIDS News 6/19/2007

A South African study published in Lancet found that HIV-positive mothers who exclusively breast-fed their babies could likely cut HIV transmission in half.

Cancer/AIDS News 4/17/2007

New Drug to Treat Advanced Breast Cancer The FDA has approved lapatinib (Tykerb, GlaxoSmithKline), a new molecular entity to be used in combination with capectabine (Xeloda, Roche Laboratories), for patients with advanced, metastatic breast cancer that is HER2 positive.

Cancer/AIDS News 2/20/2007

Number of New Cancer Patients Expected to Double The number of new cancer patients is expected to more than double in the United States over the next half-century from 1.

Advertisement